157 related articles for article (PubMed ID: 32156779)
1. RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome.
Rooney N; Mason SM; McDonald L; Däbritz JHM; Campbell KJ; Hedley A; Howard S; Athineos D; Nixon C; Clark W; Leach JDG; Sansom OJ; Edwards J; Cameron ER; Blyth K
Cancer Res; 2020 Jun; 80(11):2325-2339. PubMed ID: 32156779
[TBL] [Abstract][Full Text] [Related]
2. RUNX1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma.
Ma J; He S; Li M; Peng Y; Yang X; Chen L; Jia Q; Liu Y
Pathol Res Pract; 2023 Nov; 251():154886. PubMed ID: 37844486
[TBL] [Abstract][Full Text] [Related]
3. Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine.
Lobo NC; Gedye C; Apostoli AJ; Brown KR; Paterson J; Stickle N; Robinette M; Fleshner N; Hamilton RJ; Kulkarni G; Zlotta A; Evans A; Finelli A; Moffat J; Jewett MA; Ailles L
BMC Cancer; 2016 Jul; 16():485. PubMed ID: 27422173
[TBL] [Abstract][Full Text] [Related]
4. SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker.
Qi Y; Zhang Y; Peng Z; Wang L; Wang K; Feng D; He J; Zheng J
J Cell Mol Med; 2018 Feb; 22(2):1224-1235. PubMed ID: 29239102
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.
Gao W; Li W; Xiao T; Liu XS; Kaelin WG
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1027-1032. PubMed ID: 28082722
[TBL] [Abstract][Full Text] [Related]
6. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
Niu X; Zhang T; Liao L; Zhou L; Lindner DJ; Zhou M; Rini B; Yan Q; Yang H
Oncogene; 2012 Feb; 31(6):776-86. PubMed ID: 21725364
[TBL] [Abstract][Full Text] [Related]
7. SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.
Yu H; Liu J; Zhang Z; Zhu Y; Bi J; Kong C
J Cell Mol Med; 2021 May; 25(10):4696-4708. PubMed ID: 33787057
[TBL] [Abstract][Full Text] [Related]
8. The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma.
Nargund AM; Pham CG; Dong Y; Wang PI; Osmangeyoglu HU; Xie Y; Aras O; Han S; Oyama T; Takeda S; Ray CE; Dong Z; Berge M; Hakimi AA; Monette S; Lekaye CL; Koutcher JA; Leslie CS; Creighton CJ; Weinhold N; Lee W; Tickoo SK; Wang Z; Cheng EH; Hsieh JJ
Cell Rep; 2017 Mar; 18(12):2893-2906. PubMed ID: 28329682
[TBL] [Abstract][Full Text] [Related]
9. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
[TBL] [Abstract][Full Text] [Related]
10. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
11. ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma.
Zhu L; Ding R; Yan H; Zhang J; Lin Z
Cell Death Dis; 2020 May; 11(5):337. PubMed ID: 32382017
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns and prognostic value of RUNX genes in kidney cancer.
Gao K; Zhang F; Chen K; Li W; Guan YB; Xu ML; Chong T; Dai ZM
Sci Rep; 2021 Jul; 11(1):14934. PubMed ID: 34294773
[TBL] [Abstract][Full Text] [Related]
14. PPARγ is dispensable for clear cell renal cell carcinoma progression.
Sanchez DJ; Steger DJ; Skuli N; Bansal A; Simon MC
Mol Metab; 2018 Aug; 14():139-149. PubMed ID: 29866440
[TBL] [Abstract][Full Text] [Related]
15. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
16. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
[TBL] [Abstract][Full Text] [Related]
17. PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability.
Chen S; He Z; Peng T; Zhou F; Wang G; Qian K; Ju L; Xiao Y; Wang X
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34499617
[TBL] [Abstract][Full Text] [Related]
18. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.
Allen A; Gau D; Francoeur P; Sturm J; Wang Y; Martin R; Maranchie J; Duensing A; Kaczorowski A; Duensing S; Wu L; Lotze MT; Koes D; Storkus WJ; Roy P
J Biol Chem; 2020 Nov; 295(46):15636-15649. PubMed ID: 32883810
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1α in clear cell renal cell carcinoma.
Zhao P; Deng Y; Wu Y; Guo Q; Zhou L; Yang X; Wang C
FASEB J; 2021 Feb; 35(2):e21160. PubMed ID: 33150667
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation.
Qi Y; Ma Y; Peng Z; Wang L; Li L; Tang Y; He J; Zheng J
Oncogene; 2020 May; 39(22):4404-4420. PubMed ID: 32341409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
